🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Developing Precision Microbiota-Based Cocktail Modification Therapy to Delay the Progression of Parkinson's Disease (PD) - Use Preclinical Human Trials to Confirm the Impact of the Optimal "Probiotic Y7, Tryptophan and Branched-chain Amino Acid" Cocktail Formula on Early Stage PD Patients

RecruitingNAAges 30 Years - 85 YearsAllTaipei Medical University
NCT07619560 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Preclinical human trials will be utilized to validate the research direction, followed by clinical trials to assess the impact of a cocktail formula product containing the optimal probiotic Y7 combined metabolites on motor, cognitive, and non-motor functions in early Parkinson's disease patients. The study aims to recruit 120 patients (stage 1-3) and employ a two-arm, randomized controlled trial (RCT) design, dividing subjects into intervention and control groups for a 12 weeks trial period. Commercial development will be contingent upon the clinical trial outcomes, evaluating whether the product offers clinical benefits such as delaying Parkinson's disease progression in motor, cognitive, and non-motor functions. Additionally, a personalized and precise prognosis prediction model for Parkinson's disease will be established. This model will gather comprehensive clinical data, including m

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Subject Inclusion Criteria: 1. Age between 30-85 years old. 2. Diagnosed with early-stage Parkinson's disease (Hoehn and Yahr scale stage 1-3). 3. Brain MRI confirms striatal degeneration in the basal ganglia region, with no history of stroke. 4. Responds to Parkinson's disease-related medications (e.g., Levodopa). 5. Free of any major or acute illnesses. 6. Able to comply with the 12 weeks intervention and required assessments for the study. Exclusion Criteria: 1. Unable to complete interviews or has mobility issues. 2. Presence of major or acute illness before or during the study. 3. Co-existing intestinal co-infections, such as CDI, E. coli, Salmonella, Shigella, Campylobacter, plague, or cytomegalovirus. 4. Allergic to the intervention product. 5. Pregnant or breastfeeding women.
💊

What it tests

  • Y7
  • Placebo
📍

Where

1 site
Taipei Medical University Hospital
Taipei, Taiwan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy